Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease-Reference-Cited by-同舟云学术

Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease

Published:2013-03 Issue:3 Volume:83 Page:511-516
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Munyentwali Helene,Bouachi Khedidja,Audard Vincent,Remy Philippe,Lang Philippe,Mojaat Rachid,Deschênes Georges,Ronco Pierre M.,Plaisier Emmanuelle M.,Dahan Karine Y.

Publisher

Elsevier BV

Subject

Nephrology

Reference33 articles.

1. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children;Tarshish;J Am Soc Nephrol,1997

2. Steroid-sensitive idiopathic nephrotic syndrome in children;Niaudet,2004

3. Long-term outcome of biopsy proven, frequently relapsing minimal-change nephrotic syndrome in children;Kyrieleis;Clin J Am Soc Nephrol,2009

4. Steroid-sensitive nephrotic syndrome: from childhood to adulthood;Fakhouri;Am J Kidney Dis,2003

5. Non-corticosteroid treatment for nephrotic syndrome in children;Hodson;Cochrane Database Syst Rev,2008

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern;Nephrology Dialysis Transplantation;2024-01-13

2. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study;American Journal of Nephrology;2023-11-14

3. Clinical advances in immunotherapy for immune-mediated glomerular diseases;Clinical and Experimental Medicine;2023-10-27

4. Review of the Role of Rituximab in the Management of Adult Minimal Change Disease and Immune-Mediated Focal and Segmental Glomerulosclerosis;Glomerular Diseases;2023-08-18

5. Mechanisms and Clinical Research Progress of Rituximab in the Treatment of Adult Minimal Change Disease;Journal of Clinical Nephrology;2023-08-08